eli lilly semaglutide drug Ozempic maker slumps further in fight with Lilly, Zepbound India's Generic Weight Loss Drugs

Not everyone will experience side effects while using Wegovy, but you should be aware of the possible reactions

References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm

Mounjaro may cause approximately 2x more gastrointestinal side effects due to stronger receptor activation

Speak with your licensed healthcare provider about bone health monitoring before and during any GLP-1 treatment